Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 2 completed trials have results

Key Signals

Enrollment Performance

Analytics

Phase 2
1(33.3%)
Early Phase 1
1(33.3%)
Phase 1
1(33.3%)
3Total
Phase 2(1)
Early Phase 1(1)
Phase 1(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT02786329Early Phase 1Unknown

Anesthesia and Postoperative Outcome in Colorectal Cancer Patients

Role: collaborator

NCT04162535Phase 1Unknown

Elucidation of the Mechanisms and Effects of Certain Anesthetic Interventions on Digestive Cancer Patients Subjected to Surgery

Role: collaborator

NCT02839668Phase 2Completed

The Impact of Intravenous Anaesthesia on Angiogenesis in Patients With Breast Cancer (TIVA/TCI-BC)

Role: collaborator

NCT01487057Completed

Lipid Metabolic Status in Thyroid Carcinoma

Role: lead

All 4 trials loaded